Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vulvar Diseases × artemisinin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 3 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Precancerous Conditions 1

Interventions

fludarabine phosphate 1 fludarabine 1 artesunic acid 1 artenimol 1 artemisinin 1 aldesleukin 1 Respiratory Function Tests 1 Prochlorperazine 1 Positron-Emission Tomography 1 Ondansetron 1 O(6)-codeine methyl ether 1 Meperidine 1 Magnetic Resonance Imaging 1 Loperamide 1 Interleukin-2 1 Innovar 1 Indomethacin 1 Hydroxyzine 1 Granisetron 1 Electrocardiography 1 Droperidol 1 Doxylamine 1 Diphenoxylate 1 Diphenhydramine 1 Cyclophosphamide 1 Codeine 1 Cell Count 1 Biopsy 1 Atropine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06075264 2025-08-14

ART-VIN IIB

Frantz Viral Therapeutics, LLC

Phase 2 Recruiting

Vulvar Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡